Operating in Central and Eastern Europe (CEE) we at BIOXA are commited to bring innovative medicines, medical devices and latest biotech treatment options to patients in Czech Republic, Slovakia, Poland, Hungary, Ukraine and other markets.

Over 100 million people live in CEE. Some of CEE markets have been enjoying double digit growth in last 5-10 years. CEE represents true potential for innoivative therapeutics.

Apart from others BIOXA commercialises biotech medical products manufactured by living cell technology, recombinant technology or cell proliferation technology.